(Q40211674)

English

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.

scientific article published on April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Magali Traskine

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jens U Rüggeberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dorota Borys

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

0 references

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

3025-3034

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Serotype replacement in disease after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Issues and challenges in the development of pneumococcal protein vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40211674&oldid=1486513456"